Zenotech Laboratories Reports Record Sales Amid Mixed Financial Performance in March 2025

Zenotech Laboratories, a microcap player in the Pharmaceuticals & Drugs industry, has recently reported its financial results for the quarter ending March 2025. The results indicate a notable shift in the company's evaluation, with a revision in its score reflecting changes over the past three months. The financial data reveals that Zenotech Laboratories achieved its highest quarterly net sales in the last five quarters, reaching Rs 12.13 crore, which represents a growth of 21.2% compared to the average net sales of the previous four quarters. Additionally, the operating profit also marked a peak at Rs 4.47 crore, with an operating profit margin of 36.85%, indicating enhanced efficiency within the company. However, not all aspects of the financial performance were favorable. The profit after tax for the latest six months was reported at Rs 2.60 crore, showing a decline of 35.26% year on year, suggesting challenges in this area. Overall, Zenotech Laboratories has experienced evaluation changes that reflect a complex financial landscape, with both positive trends in sales and operating profit, alongside challenges in profit after tax. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.